Indeed, studies aiming at reducing the expression of HSC70 and HSP70 simultaneously in combination with HSP90 inhibition showed a remarkable increase in toxicity and cell death suggesting that a combined treatment could prove to be effective in the management of various types of cancer including glioblastoma [11,12]. Here, HSPA8 is linked to cancer.